VALARTH See the full analysis in the appOpen in app
Sectoral / Thematic · Equity

Aditya Birla Sun Life Pharma & Healthcare Fund

Aditya Birla Sun Life AMC Limited
Benchmark
BSE Healthcare TRI
Riskometer
Very High
Size
₹1,065 cr
Allotted
11 Jul 2019
Holdings as of
30 Sep 2026

Aditya Birla Sun Life Pharma & Healthcare Fund is a sectoral / thematic fund of Aditya Birla Sun Life AMC Limited with ₹1,065 cr under management. It is ahead of its benchmark (BSE Healthcare TRI) in 1 of 3 periods. Its direct plan charges 1.07% a year. Dhaval Shah has managed it for 7.3 years.

Has Aditya Birla Sun Life Pharma & Healthcare Fund beaten its benchmark?

Ahead of its benchmark, BSE Healthcare TRI, in 1 of 3 periods in AMFI's figures; +12.19% over the last year against +9.74%.

Period returns

Direct Plan, growth · 3y and longer a year
PeriodFundNifty 500 TRIAhead
1 month−5.48% −3.60% —
3 months−4.16% −5.03% —
6 months+11.68% −1.83% —
1 year+12.04% −4.06% +16.10 pts
3 years+19.06% +9.27% +9.79 pts
5 years+13.06% +8.00% +5.06 pts
10 years— +12.69% —
Since start
from 11 Jul 2019
+20.22%——
Valarth price history to 14 Oct 2026 · the index is the one the fund is nearest; — not on record

Official figures

AMFI performance feed, 13 Oct 2026
Ahead of its benchmark (BSE Healthcare TRI) in 1 of 3 periods.
PeriodDirectRegularBenchmarkAheadRank
1y +12.19%+10.73%+9.74% +2.45 🔒
3y +19.33%+17.75%+20.52% −1.19 🔒
5y +13.26%+11.70%+13.76% −0.50 🔒
10y ——— — —
Ahead in points a year · its rank among Sectoral / Thematic funds, and how steady the lead is, in the app

Value of 100, month-end

Jul 2019 to 14 Oct 2026
50100150200250300350400450 202120232025
Fund 377Nifty 500 TRI 262

₹100 put in at the start of Jul 2019 would be ₹377 on 14 Oct 2026, against ₹262 in the Nifty 500 TRI.

Risk, falls and every year

🔒 Pro
Its worst fall and how long it took to recover, three-year stretches, Sharpe, beta and capture ratios, calendar years beside the index, and money in and out: in the app.
See them in the app →

What does Aditya Birla Sun Life Pharma & Healthcare Fund cost?

1.07% a year on the direct plan, 2.30% on the regular plan; 58 of 174 funds in its category charge less.

Direct plan
1.07% a year
Category median 1.22%
Regular plan
2.30% a year
Category median 2.38%
Gap
1.23 points
for the same holdings
58 of 174 funds in its category charge less on the direct plan.
Expense report, Oct 2026 · Equity Scheme - Sectoral/ Thematic

What the regular plan costs you over time

🔒 Pro
The same money left for years in the direct and the regular plan, side by side, and what the commission takes: in the app.

Who manages Aditya Birla Sun Life Pharma & Healthcare Fund?

Dhaval Shah, since 11 Jul 2019.

Dhaval Shah
Primary
7.3 years
since 11 Jul 2019
Benchmark as filedBSE Healthcare TRI
Exit load
For redemption/switch-out of units on or before 30 days from the date of allotment: 1.00% of applicable NAV. For redemption/switch-out of units after 30 days from the date of allotment: Nil
From 3 Scheme Summary Documents filed with NSE, first on 26 Aug 2026; as on 9 Sep 2026

What does Aditya Birla Sun Life Pharma & Healthcare Fund hold?

41 holdings as of 30 Sep 2026; the ten largest are 54.4% of the fund, the largest Torrent Pharmaceuticals Ltd. at 9.3%.

Mix

Holdings as of 30 Sep 2026
Equity97.9%Debt0.0%Cash2.1%Other0.0%
Holdings
41
39 shares
Top ten
54.4%
of the fund
Effective holdings
22.9
spread, as if equal-weighted
Matched to our table
100%
of the equity

Five largest

% of fund
Torrent Pharmaceuticals Ltd.9.28%
Sun Pharmaceutical Industries Ltd.8.61%
Apollo Hospitals Enterprise Ltd.6.44%
Cipla Ltd.6.38%
Aurobindo Pharma Ltd.4.52%

Five largest industries

% of fund
Pharmaceuticals & Biotechnology76.5%
Healthcare Services22.1%
Insurance0.70%
Chemicals & Petrochemicals0.70%

By company size

% of equity · SEBI size lists
Large Cap33.6%Mid Cap32.4%Small Cap34.0%

How does Aditya Birla Sun Life Pharma & Healthcare Fund score against its category?

Seven scores against funds of its kind, and the warning signs it trips.

Scorecard

🔒 Pro
Seven scores, each out of 5, against funds in its category, with the reasons, and the warning signs it trips: in the app.
Open scorecard in the app →

Are the companies inside any good?

The holdings by valuation, forensic risk, business quality and balance sheet, weighted by their share of the fund.

The companies inside

🔒 Pro
The holdings weighted by their share of the fund: P/E and ROE, forensic risk levels, Valarth's valuation view, quality, moats, balance sheets and who owns them: in the app.

How is Aditya Birla Sun Life Pharma & Healthcare Fund run?

Turnover, what it bought and sold, its cash and its record in new listings, from its monthly holdings files.

How it is run

🔒 Pro
Turnover, what it bought and sold and when, how long it holds, size drift, cash and its record in new listings, from up to two years of monthly holdings files: in the app.

Which funds hold much the same?

The index it is nearest and the funds whose holdings overlap most.

not an index tracker
Nearest to the Nifty Midcap 150: 93% of it differs from the index (an active fund is usually above 60%).
Active share 92.7%60%

Funds that hold much the same

% of holdings in common
NIPPON INDIA PHARMA FUND65.3% the same
28 shared holdings
Mirae Asset Nifty 500 Healthcare ETF57.5% the same
26 shared holdings
Baroda BNP Paribas Health and Wellness Fund56.6% the same
20 shared holdings

How much is in its sponsor's own group?

Holdings in companies of the fund house's sponsor group, beside the index.

Related-party exposure

🔒 Pro
How much of the fund is in companies of its sponsor's own group, beside what the index holds of them: in the app.

Questions people ask

Who manages Aditya Birla Sun Life Pharma & Healthcare Fund?

Dhaval Shah (Primary) since 11 Jul 2019.

What is the expense ratio of Aditya Birla Sun Life Pharma & Healthcare Fund?

1.07% a year on the direct plan and 2.30% on the regular plan (expense report, Oct 2026).

How has Aditya Birla Sun Life Pharma & Healthcare Fund done?

Its direct plan returned +19.33% a year over 3 years against +20.52% for its benchmark, BSE Healthcare TRI, as of 13 Oct 2026.

Inside the app

See Aditya Birla Sun Life Pharma & Healthcare Fund beside your own funds in Valarth

Start freeStart free
A Valarth stock page: the share price with its chart and 52-week range, valuation and profitability figures, and a scorecard of health checks.
Stock pagePrice, valuation, profitability and a scorecard of health checks for every company, each figure explained.
The Valarth stock screener: a table of companies with price, market cap, P/E, P/B, PEG, EPS and ROE, and filters down the left.
ScreenerEvery listed company, filtered on 212 figures, each with a plain-language lesson beside it.
The Valarth AI Screener answering 'Which companies will benefit from India's Project 75 submarine programme?' with a basket of four naval shipbuilders and a written thesis.
AI ScreenerAsk a question in plain English, like which companies benefit from India's Project 75. It reads the intent, builds the screen and writes the thesis.
A Valarth business-model card for State Bank of India, with a plain-language summary and statements verified against the filing.
Business modelHow a company makes money and what can hurt it, each statement checked against its annual report.
Valarth's Before the Bell edition, with the day's headline, regulator notes and sector moves.
Before the BellA morning edition before the market opens: what moved, which rule changed, and what it means for your holdings.

Aditya Birla Sun Life Pharma & Healthcare Fund in the app: beside your own funds, with what you own through them

See the full analysis in the app →See pricing
Share this page